novo nordisk semaglutide oral Novo's Wegovy: Dead-Cat Bounce or True Inflection? With FDA approval of Wegovy

(00:29:14) Uh, everything else is, I can look at

Week-by-Week Expectations Weeks 1 to 2

Medium pink, closer to a strawberry milkshake, can occur with slightly higher B12 concentrations or when the formulation is newer and has not had time for any light-related fading

Clinical data shows that approximately 25% of weight lost on GLP-1 medications comes from lean mass, making muscle preservation strategies increasingly relevant for researchers exploring optimal body composition outcomes

Side effect mitigation Semaglutide has gastrointestinal side effects such as nausea, vomiting, excessive burping, abdominal discomfort, stomach pain, constipation, and diarrhea

[PMID: 23700736] PubMed record related to this compound for laboratory literature review